ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
University Hospital Münster at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University Hospital Münster takes part in 4 sessions at ESMO 2026 in Madrid. Its work focuses on prostate cancer, soft tissue sarcoma and risk assessment in gastrointestinal stromal tumours. It examines a targeted radioactive treatment for metastatic prostate cancer and molecular scoring to estimate GIST prognosis.
| Organization | ESMO 2026 Attendance |
|---|---|
University Hospital Münster Münster, Germany | |
University hospital providing specialist cancer care in Münster, Germany. | Poster Fri Oct 23 15:15–16:00 Satellite Sat Oct 24 13:30–13:55 Radiopharmaceuticals in Prostate Cancer: From PSMA Based Diagnostics to Emerging Genitourinary cancers Poster Mon Oct 26 12:00–12:45 Talk Mon Oct 26 14:45–15:05 (Re)Defining the prognosis of GIST: Digital pathology, molecular risk scoring and clinical implications Sarcoma, CNS, head & neck and rare cancers Chair Mon Oct 26 14:45–16:15 Optimising GIST management: From prognostic insights to new therapeutic strategies Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at University Hospital Münster
Tell us what you sell and we’ll find the people at University Hospital Münster most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction